Market research
WLLW.TO Willow Biosciences Inc
TO CAD Healthcare
Latest close
As of 17 Sep 2025
Test a moving-average rule with historical data.
Market facts
- Market cap
- 5M
- P/E ratio
- Not available
- Analyst target
- 2
- Dividend yield
- Not available
- Beta
- 4.65
Profile
Instrument facts
- Exchange
- TO
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- CA97111B4047
- Market cap
- 5M
- P/E ratio
- Not available
- Analyst target
- 2
- Dividend yield
- Not available
- Beta
- 4.65
About
About Willow Biosciences Inc
Willow Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has licensing and development partnership with Laurus Labs to develop and commercialize active pharmaceutical ingredients and other ingredients. Willow Biosciences Inc. was founded in 2019 and is headquartered in Calgary, Canada.
Research context
Willow Biosciences Inc appears in PyInvesting’s Toronto Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the WLLW.TO discussion.
5 years, 6 months ago
Willow Biosciences Inc is currently in a long term downtrend where the price is trading 13.1% below its 200 day moving average.
From a valuation standpoint, the stock is 1089.3% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 12135.1.
Willow Biosciences Inc's total revenue rose by inf% to $8K since the same quarter in the previous year.
Its net income has dropped by 380.1% to $-15M since the same quarter in the previous year.
Finally, its free cash flow grew by 15.7% to $-4M since the same quarter in the previous year.
Based on the above factors, Willow Biosciences Inc gets an overall score of 2/5.